全文获取类型
收费全文 | 1423篇 |
免费 | 114篇 |
国内免费 | 59篇 |
专业分类
儿科学 | 71篇 |
妇产科学 | 27篇 |
基础医学 | 148篇 |
口腔科学 | 16篇 |
临床医学 | 189篇 |
内科学 | 292篇 |
皮肤病学 | 19篇 |
神经病学 | 66篇 |
特种医学 | 257篇 |
外科学 | 137篇 |
综合类 | 29篇 |
预防医学 | 125篇 |
眼科学 | 12篇 |
药学 | 113篇 |
中国医学 | 3篇 |
肿瘤学 | 92篇 |
出版年
2023年 | 6篇 |
2022年 | 5篇 |
2021年 | 22篇 |
2020年 | 13篇 |
2019年 | 17篇 |
2018年 | 34篇 |
2017年 | 11篇 |
2016年 | 13篇 |
2015年 | 34篇 |
2014年 | 31篇 |
2013年 | 47篇 |
2012年 | 43篇 |
2011年 | 49篇 |
2010年 | 45篇 |
2009年 | 34篇 |
2008年 | 30篇 |
2007年 | 81篇 |
2006年 | 33篇 |
2005年 | 46篇 |
2004年 | 30篇 |
2003年 | 23篇 |
2002年 | 33篇 |
2001年 | 30篇 |
2000年 | 27篇 |
1999年 | 35篇 |
1998年 | 65篇 |
1997年 | 48篇 |
1996年 | 63篇 |
1995年 | 56篇 |
1994年 | 44篇 |
1993年 | 57篇 |
1992年 | 25篇 |
1991年 | 20篇 |
1990年 | 34篇 |
1989年 | 39篇 |
1988年 | 45篇 |
1987年 | 44篇 |
1986年 | 41篇 |
1985年 | 35篇 |
1984年 | 23篇 |
1983年 | 14篇 |
1982年 | 18篇 |
1981年 | 26篇 |
1980年 | 23篇 |
1979年 | 15篇 |
1978年 | 16篇 |
1977年 | 21篇 |
1976年 | 12篇 |
1975年 | 11篇 |
1974年 | 6篇 |
排序方式: 共有1596条查询结果,搜索用时 15 毫秒
1.
2.
3.
4.
Eain M. Cornford Deborah Young James W. Paxton 《Cancer chemotherapy and pharmacology》1992,29(6):439-444
Summary The blood-brain barrier penetration of amsacrine and its analogs 9-({2-methoxy-4-[(methylsulfonyl)-amino]phenyl}amino)-,5-dimethyl-4-acridine carboxamide (CI-921) and M-[2-(dimethylamino)ethyl]-acridine-4-carboxamide (AC) was measured in the barbiturate-anesthetized mouse. After intracarotid administration, AC was almost completery extracted (90%) in a single transit through the brain capillaries, whereas CI-921 (20%) and amsacrine (15%) were moderately extracted. AC is retained in the brain; no loss of AC from the brain was apparent at 1, 2, 4, or 8 min after injection. In contrast, after intraportal administration, 75% of the AC, 94% of the CI-921, and 57% of the amsacrine was extracted in a single transit through the hepatic vasculature. Rather than being retained in the mouse liver, these acridine antitumor agents show time-dependent loss (t
1/2=10 min for amsacrine and AC, 24 min for CI-921). We conclude that unlike most antitumor agents, these acridine drugs appear to penetrate the blood-brain barrier readily.This study was supported by the Auckland Medical Research Foundation (New Zealand), by the Medical Research Foundation (New Zealand), by the National Science Foundation (United States/New Zealand Cooperative Science Program), by the United States Veterans Administration, and by NIH grant NS 25554 相似文献
5.
6.
Christian J Streck Paxton V Dickson Catherine Y C Ng Junfang Zhou John T Gray Amit C Nathwani Andrew M Davidoff 《Clinical cancer research》2005,11(16):6020-6029
PURPOSE: Type I IFNs (IFN-alpha/beta) have shown significant antitumor activity in preclinical models but limited efficacy and significant toxicity in clinical trials. We hypothesized that the antitumor activity of type I IFNs could be enhanced by chronic, low-dose systemic delivery and sought to test this in murine neuroblastoma models. EXPERIMENTAL DESIGN: Continuous liver-generated expression of human IFN-beta (hINF-beta) was achieved through a gene therapy-mediated approach using adeno-associated virus vectors encoding hIFN-beta (AAV hINF-beta). Orthotopic localized retroperitoneal and disseminated models of neuroblastoma were established using three different xenografts. Immunohistochemical analysis and ELISA were used to evaluate the antiangiogenic effect of therapy. RESULTS: The development of both localized orthotopic (retroperitoneal) and disseminated neuroblastoma was prevented in all mice expressing hINF-beta. Continued growth of established retroperitoneal tumors, treated with AAV hINF-beta as monotherapy, was significantly restricted, and survival for mice with established, disseminated disease was significantly prolonged following administration of AAV hINF-beta. Analysis of treated tumors revealed a significant antiangiogenic effect. Mean intratumoral vessel density was diminished and expression of the angiogenic factors vascular endothelial growth factor and basic fibroblast growth factor were both decreased. Finally, combination therapy in which AAV hIFN-beta was used together with low-dose cyclophosphamide resulted in regression of both established retroperitoneal and disseminated disease. CONCLUSIONS: AAV-mediated delivery of hIFN-beta when used as monotherapy was able to restrict neuroblastoma growth due in part to inhibition of angiogenesis. When used in combination with conventional chemotherapy, AAV hIFN-beta was able to effect complete tumor regression. 相似文献
7.
Short-Ti inversion-recovery pulse sequence: analysis and initial experience in cancer imaging 总被引:2,自引:0,他引:2
Inversion recovery (IR), commonly considered a pulse sequence capable of producing T1-weighted images with excellent display of normal anatomy, is versatile: The null point and peak time provide a useful, succinct summary of the properties of IR and its capacity for producing both T1- and T2-weighted images. Shortening of the inversion time (TI) and creation of a short-TI inversion-recovery (STIR) pulse sequence increases sensitivity to malignancy and other abnormalities by making the effects of prolonged T1 and T2 on signal intensity additive and by nulling the signal from fat. The authors examined over 300 patients with various malignancies and compared STIR images with T1- and T2-weighted images obtained at 0.5 T. In 43 cases, signal-difference-to-noise ratios (SD/Ns) were calculated between tumor, fat, and muscle. In general, STIR images demonstrated tumor as a conspicuously high-intensity area in a background of muted, discernible anatomic detail. The good contrast achieved with STIR sequences between tumor and fat (SD/N = 18.1) and tumor and muscle (SD/N = 12.9) consolidated into a single image the information contained separately on T1- and T2-weighted images, which facilitates efficient detection and localization of malignancy. 相似文献
8.
Sixteen cases of histopathologically proved solitary rectal ulcer syndrome were encountered. Fifteen patients underwent barium enema study; in nine cases the findings--including rectal stricture, granularity of the mucosa, and thickened rectal folds-were nonspecific. In six cases the study was normal. All patients had a long history of defecation disorders, and defecography was performed in all. In seven cases, intussusception of the rectal wall was seen; in another case the intussusception was accompanied by a rectocele. One case showed rectal prolapse. In four cases, failed relaxation of the puborectalis occurred and prevented the passage of the bolus; in another case there was abnormal perineal descent. In two patients studies were normal. In patients with defecation disorders, the possibility of this syndrome should be considered. Defecography is the method of choice for establishing the diagnosis. 相似文献
9.
10.
The binding of amsacrine to human plasma proteins 总被引:1,自引:0,他引:1
Determination of amsacrine plasma protein binding by both equilibrium dialysis and ultracentrifugation gave similar results and indicated that amsacrine is highly bound (approximately 97%) in human plasma. This binding is independent of amsacrine concentration over the range 1-100 mumol litre-1, but is very sensitive to plasma pH and, to a lesser extent, to temperature. Approximately 20% of the drug appeared to be covalently bound to plasma proteins. Amsacrine was bound by all plasma proteins investigated including albumin, alpha 1-acid glycoprotein and various gamma-globulins. The binding to albumin appeared to occur by two processes, a saturable process at a single site with a KD of 13.9 mumol litre-1 and a non-saturable process. Despite differences in individual protein concentrations, no significant difference was observed in the unbound amsacrine fraction in plasma from patients receiving this drug for treatment of acute myelogenous leukaemia and plasma from healthy individuals. 相似文献